07/01/2024
Changes Due to the Inflation Reduction Act
The Inflation Reduction Act of 2022 introduced significant changes to Medicare Part D, focusing on reducing prescription drug costs for enrollees. Here are the biggest changes:
1. Out-of-Pocket Spending Cap: Starting in 2025, Medicare Part D will implement a $2,000 cap on out-of-pocket spending for prescription drugs. This cap will be adjusted annually based on the growth rate of per capita Part D costs, significantly reducing the financial burden for beneficiaries who require high-cost medications.
2. Elimination of the Coverage Gap: Also known as the "donut hole," the coverage gap phase where beneficiaries faced higher costs for their medications will be eliminated in 2025. This will simplify the benefit structure and reduce out-of-pocket expenses for enrollees.
3. Insulin and Vaccines: Since 2023, the cost of insulin has been capped at $35 per month, and adult vaccines recommended by the Advisory Committee on Immunization Practices (such as the shingles vaccine) are provided without cost-sharing.
4. Changes in Catastrophic Coverage: In 2024, the 5% coinsurance requirement for catastrophic coverage will be eliminated, shifting a larger share of costs to Part D plans. By 2025, Part D plans will cover 60% of drug costs in the catastrophic phase, with pharmaceutical manufacturers providing a 20% discount on brand-name drugs.
5. Low-Income Subsidy (LIS) Program Expansion: Starting in 2024, eligibility for full benefits under the Part D LIS program will extend to individuals with incomes up to 150% of the federal poverty level, enhancing access to reduced drug costs for more low-income beneficiaries.
6. Manufacturer Discount Program: In 2025, the current Coverage Gap Discount Program will be replaced by the Manufacturer Discount Program. Drug manufacturers will provide a 10% discount on brand-name drugs during the initial coverage phase and a 20% discount in the catastrophic phase, increasing their financial contributions to the program.
These changes aim to make prescription drugs more affordable for Medicare beneficiaries while redistributing costs among the federal government, insurance plans, and pharmaceutical companies.
We will not have final plans information to share with clients and referrals until October 1st. We strive to get you as much information as we legally can now to keep you updated. This is not the year to "set it and forget it" on your drug plans and or Medicare Advantage plans. Be in the know and work with us at no charge.
DCD Financial & Insurance Services
www.lowcostcahealth.com